- Filed
- May 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 26, 2026 | 16.23B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 16.18B sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.71B sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $7.5K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.51M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$221.34K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $3.31M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $828.01K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $26.42M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $24.21M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $27.53M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $26.71M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.43M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.18M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.07M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.75M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.29M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$656.41K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$501.36K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$930.95K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $554.13K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $504.65K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.45M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $900.02K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.4M |